Guild BioSciences is a bioscience technology development business unit of Guild Associates. Our focus is the development and commercialization of novel, enabling bioscience technology. Guild BioSciences has three main areas of interest: Diagnostics, Therapeutics, and Specialty Biomaterials. PRODUCTS: Our M13mp18 based ssDNA scaffolds are used by the DNA Origami research community. Guild BioSciences' patented, low-cost enzyme immobilization technology, ImmobiZyme™, uses novel support materials, including biodegradable materials, and can be customer configured to impart a broad range of properties. RESEARCH AND DEVELOPMENT In addition to the products above, Guild BioSciences is an active participant in research and development. We have been funded by many government agencies including DoD, NIH, USDA, and NSF. Guild BioSciences maintains many relationships with universities, commercial companies, and government agencies.
Looking for a particular Guild BioSciences employee's phone or email?
The Guild BioSciences annual revenue was $11 million in 2026.
Andrew Dinovo is the Vice President of Guild BioSciences Operations of Guild BioSciences.
4 people are employed at Guild BioSciences.
Guild BioSciences is based in Dublin, Ohio.
The NAICS codes for Guild BioSciences are [541, 54, 541713, 5417, 54171].
The SIC codes for Guild BioSciences are [87, 873].